Vaping-related lung illnesses have risen to 530 cases; 2 invasive species of mosquitoes are spreading across California; US pays $3 million toward research on medicinal marijuana.
The incidence of mysterious lung illnesses related to vaping has increased to 530 reported cases across 38 states, according to The Washington Post. The outbreak of vaping-related illnesses has now accounted for 8 deaths across the nation, leading to intervention by the FDA. Federal officials said that the enforcement arm of the FDA has been conducting a probe in parallel with the public health investigation led by the CDC. The root cause of these illnesses and deaths has yet to be found, but officials disclosed that all reported cases show a history of e-cigarette or vaping use. Many of the affected individuals had a history of using e-cigarette products containing tetrahydrocannabinol (THC), the psychoactive compound that produces marijuana’s high, as well as many reported cases involving vaping both nicotine and THC, and some reporting vaping solely nicotine products.
Invasive species of mosquitoes carrying Zika, dengue, yellow fever, and other dangerous viruses are spreading across California, with 2 species currently found. California Healthline reported that these mosquitoes have been found as far north as Sacramento and Placer counties, which now brings the total to 16 counties containing Aedes aegypti, the mosquito species that causes yellow fever. Of these counties, 5 have additionally detected the species Aedes albopictus, known as the Asian tiger mosquito. These mosquitoes can spread the Zika virus, which created an epidemic in 2015 within Brazil and can be sexually transmitted after infection. Microcephaly, a condition which inhibits the development of a baby’s brain and causes their head to be much smaller than usual, is a known effect of the Zika virus.
Researchers will receive federal grants to study the effectiveness of cannabidiol (CBD), a component in marijuana, for relieving pain, according to the Associated Press. The US government will spend $3 million in total, allocated as 9 research grants, on testing CBD and many other lesser-known chemicals, but it notably excluded THC as part of its research. Marijuana is currently still considered an illegal drug by the federal government, but it is now allowed for medicinal purposes in 30 states. Delineating which chemical components in marijuana result in the highest effectiveness for treating chronic pain, and additionally whether these chemicals can eliminate the need for THC, are key objectives for research.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512